Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...
Proteus Digital Health could exit bankruptcy in a deal with Otsuka Pharmaceutical, one of its main customers. Proteus, founded in 2001, develops ingestible sensors and a wearable sensor patch to track ...
After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to ...
Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...
The “Beyond the Pill” movement marked a major milestone with the FDA’s acceptance of the first digital medicine-New Drug Application. It will pair Proteus Digital Health’s ingestible sensor platform ...
Proteus Digital Health has announced it has received FDA clearance for an ingestible sensor, according to a news release. The ingestible sensor, formally referred to as the Ingestion Event Marker, can ...
PROTEUS INGESTIBLE SENSOR by Proteus Digital Health Proteus Digital Health announced today that the FDA has cleared its ingestible sensor for marketing as a new category of medical device. Proteus ...
A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". TOKYO and REDWOOD CITY, Calif., Nov. 14, 2017 /PRNewswire/ -- Otsuka ...
Proteus’s sensors attach to the pills patients swallow-and then tell doctors how their bodies respond.. Yudi Ela; Prop styling: Astrid Chastka/Hello Artists Many people forget to take their pills or ...
REDWOOD CITY, Calif. – July 30, 2012 – Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback